Plné znění - 261/2015 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016

261/2015 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

261

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx dne 22. xxxx 2015

o xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2016

 

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx x o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx pro xxx 2016:

1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), tetanu, xxxxxx přenosné obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Haemophilus influenzae xxx b (XXxXXxxXXXXXX):

Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx xxx 30 mezinárodních xxxxxxxx (IU)

Tetani xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 25 mikrogramů

Haemagglutininum xxxxxxxxxxxx1 25 mikrogramů

Pertactinum1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx

Xxxxx poliomyelitis (xxxxxxxxxxxx)

xxxxx 1 (kmen Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (kmen XXX-1)4 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx)4 32 X jednotek xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 mikrogramů

(polyribosylribitoli xxxxxxxx)3

xxxxxxxxx xxx tetani xxxxxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (acelulárni xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (inaktivovaná xxxxx), xxxxxx xxxxxxxxxx X, nákazám vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)

Xxxxxxxxxxx xxxxxxxxxx xx xxxx než 20 xxxxxxxxxxxxx jednotek (XX)2

Xxxxxx anatoxinum xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx

Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3

xxxxx 1 (Xxxxxxx) 40 D jednotek xxxxxxxx4

xxxxx 2 (XXX-1) 8 D jednotek xxxxxxxx4

xxxxx 3 (Saukett) 32 X jednotek xxxxxxxx4

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx 12 xxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx cum xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum filamentosum (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 mikrogramů

NEBO

1ba) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx kašli (acelulární)

1 xxxxx (0,5 xx) xxxxxxxx:	Xxxxxxxxx 2 IU* (2 Xx)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx	Xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum	5 xxxxxxxxxx
Xxxxxxxxxxx	3 xxxxxxxxxx
Xxxxxxxx, typi 2 xx 3	5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx	1,5 mg (0,33 xx hliníku)

NEBO

1bb) Očkovací xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (acelulární komponenta) xx sníženým xxxxxxx xxxxxxxx

Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (IU) (2,5 Lf)

Tetani anatoxinum1 xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1

8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum1 2,5 xxxxxxxxxx

1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (XX(XX)3) 0,3 miligramů XX3+ x xxxxxxxxxxx xxxxxxx (XXXX4) 0,2 xxxxxxxxx AI3+

1c) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxxx xxxxxxxxx Hemofilem influenzae x (XXxXXxx):

Xxxxxxxxxxx anatoxinum	min. 30 xxxxxxxxxxxxx jednotek
Tetani xxxxxxxxxx	xxx. 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX)	25 xxxxxxxxxx
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX)	25 mikrogramů
Pertactinum (69kD)	8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx B	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) očkovací látka xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae xxx x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (25 mikrogramů).

1e) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx 16 xxx x xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu₅₀

Parotitidis virus xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro buněčnou xxxxxxx₅₀

Xxxxxxxx virus attenuatum (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx typus 2 (XXX-1) ......... 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ...... 32 antigenních X xxxxxxxx*

* xxxx množství xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx vhodné imunochemické xxxxxx.

1xx) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx typus:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9V, 10A, 11X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X ... 25 mikrogramů x xxxxxxx xxxxxxxx

1x) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4

Pneumococcale xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 14

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 18C

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 19A

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx xxxxxxxxxx	xx xxxx xxx 2 xxxxxxxxxxx jednotky
Tetani xxxxxxxxxx	xx xxxx xxx 20 xxxxxxxxxxxxx jednotek

Pertusové xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx	8 mikrogramů
Pertaktin	2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx inactivatum:

typus 1 (xxxx Mahoney)	40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)	8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)	32 D xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx	xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
Xxxxxxxxx xxxxxx	xxxx xxxx rovno 20 xxxxxxxxxxxxx jednotek (5 Xx)

Xxxxxxxxx antigeny:

Pertusový xxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxx xxxx 2+3	5 xxxxxxxxxx
Xxxxxxxxx	3 mikrogramy

-

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx X jednotek
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 xxxxxxxxxxx D xxxxxxxx
Xxxxx poliomyelitis xxxx 3 (inaktivovaný)	32 antigenních X xxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (BCG) xxxxxxx Danisuc 1331.....0,75 xx

&xx;2,0 x 10⁶ ≤ 8,0 x 10⁶ CFU (živých xxxxxxx)

1x) xxxxxxxx látka xxxxx virové hepatitidě X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; adjuvans AS04C xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 mikrogramů x 1 xxxxx

1x) Xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě B x xxxxxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X 10 mikrogramů x 0,5 xx xxxxxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 mikrogramů

2b) xxxxxxxx látka proti xxxxxxxxx

Xxxxx rabiei inactivatum (xxxx Wistar xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx v 1 dávce (0,5 xx)

2x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx A xxxxx inactivatum

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx xxxx:

Xxxxx hepatitis X xxxxxxxxxxx

 

X xxxx 2016 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx infekčním xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, nelze xxxxxxxx xxxxxxxxx úpravu xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx zákonů.

 

Ministr:

v x. XXXx. Policar x. x.

xxxxxxxx pro xxxxxxxxxxx x xxxxx

Xxxxxxxxx

Xxxxxx předpis x. 261/2015 Sb. xxxxx xxxxxxxxx xxxx 24.10.2015.

Xx xxxxx xxxxxx právního xxxxxxxx xxxx podchyceny xxxxx x doplnění xxxxxxxxxxx xxxxxxx předpisem x.:

131/2016 Xx., kterým xx mění xxxxxxx x. 261/2015 Xx., x xxxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx, zvláštní x xxxxxxxxx očkování pro xxx 2016

x účinností xx 10.5.2016

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.